Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
Azora Therapeutics commenced trading on Nasdaq as “AZR”New executive team and Board of Directors appointedAT177 IND submission and Phase 1a initiation on track for the first half of 2027LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Azora Therapeutics, Inc. NASDAQ:AZR (“Azora” or the “Company”), a…